Coagulation Protein Disorders D020147

Diseases [C] » Hemic and Lymphatic Diseases [C15] » Hematologic Diseases » Blood Coagulation Disorders » Coagulation Protein Disorders

Description

Hemorrhagic and thrombotic disorders resulting from abnormalities or deficiencies of coagulation proteins.   MeSH

Hierarchy View

Subtype Terms (12)

Activated Protein C Resistance
2 approved drugs

Afibrinogenemia
2 approved drugs

Factor V Deficiency
 

Factor VII Deficiency
6 drugs (3 approved, 3 experimental)

Factor X Deficiency
1 approved drug

Factor XI Deficiency
1 approved drug

Factor XII Deficiency
 

Factor XIII Deficiency
1 approved drug

Hemophilia A
89 drugs (43 approved, 46 experimental)

Hemophilia B
43 drugs (13 approved, 30 experimental)

Hypoprothrombinemias
2 approved drugs

von Willebrand Diseases
16 drugs (7 approved, 9 experimental)


Other Experimental Indicated Drugs (2)


Organization Involved with Phase 3 Indications (2)

Organization Involved with Phase 2 Indications (2)

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.